A Study of TAK-954 to Treat Gastrointestinal Dysfunction in Adults After Surgery
a study on Postoperative Gastrointestinal Dysfunction
Postoperative Gastrointestinal Dysfunction Drug Therapy TAK-954 TAK-954 0.5 mg/100 mL
Lead Scientist at UC Irvine
- Joseph Carmichael
Health Sciences Professor, Surgery. Authored (or co-authored) 112 research publications.
- accepting new patients
- Start Date
- Completion Date
- To obtain more information on the study, click here/on this link.
- Phase 2
- Study Type
- Last Updated